EUVIMEDEUVIMED entdecken
Crossref

Stability‐Indicating RP‐HPLC Method Development and Validation for Quantification of Butylated Hydroxyanisole Content in Loperamide Oral Solid Dosage Form

Prasanna Kumar Lankalapalli iD, Srinivasulu Kasa, Pranitha Sambu iD, Rama Krishna Myneni iD, Teja Kamireddy iD, Vijaykumar Chollety, Hareesh Divadari iD

Biomedical Chromatography · 2025

DOI: 10.1002/bmc.70103 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomedical Chromatography, 2025. Verfasst von Prasanna Kumar Lankalapalli und 6 weiteren Autor:innen. Beteiligte Einrichtung: Visual Technologies LLC, Plano, Texas, USA. Hauptthemen laut MEDLINE: Loperamide, Butylated Hydroxyanisole, Chromatography, Reverse-Phase. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 29 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The present study discusses the development of a simple, rapid, and specific high‐performance liquid chromatography (HPLC) method for the estimation of butylated hydroxyanisole (BHA) in loperamide HCl capsule dosage formulations. The developed HPLC method was validated in accordance with current ICH guidelines. Chromatographic separation was achieved using a phosphate buffer (pH 6.8) as mobile phase A and a mixture of acetonitrile and buffer in a ratio of 80:20 (v/v) as mobile phase B. The flow rate was 0.8 mL/min, and column temperature was maintained at 35°C. Detection of the component was performed at 290 nm for BHA. The optimized HPLC method was validated as per current ICH guidelines and demonstrated high specificity with a linearity range of 13–83 μg/mL for BHA, with a correlation coefficient greater than 0.999. The method showed accuracy exceeding 97%. Stress studies revealed that BHA is sensitive to peroxide stress conditions. The results highlight the successful applicability of the current method for estimating BHA in marketed formulations, which can be further utilized to evaluate other formulation systems. The developed method was validated according to international ICH guidelines concerning specificity, linearity, precision, and accuracy. The method was developed and validated in a quality control lab for stability analysis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LoperamideButylated HydroxyanisoleChromatography, Reverse-PhaseChromatography, High Pressure LiquidReproducibility of ResultsLinear ModelsLimit of DetectionDrug StabilityAdministration, OralSensitivity and Specificity

Stichwörter der Autor:innen

HPLCbutyl hydroxyanisole (BHA)(2‐tert‐BHA and 3‐tert‐BHA)loperamide HCLmethod developmentvalidation

Substanzen

LoperamideButylated Hydroxyanisole

Autor:innen und Institutionen

  • Visual Technologies LLC, Plano, Texas, USA.
  • Osmania University, Hyderabad, India.
  • Aurex Laboratories Pvt Ltd., Hyderabad, India.
  • Stira Pharmaceuticals LLC, Fairfield, New Jersey, USA.
  • August Bioservices, Nashville, Tennessee, USA.
  • Ascent Pharmaceuticals Inc., Central Islip, New York, USA.

ORCID-Profile: Prasanna Kumar Lankalapalli, Pranitha Sambu, Rama Krishna Myneni, Teja Kamireddy, Hareesh Divadari

Zitieren

APA

Lankalapalli, P. K., Kasa, S., Sambu, P., Myneni, R. K., Kamireddy, T., Chollety, V., & Divadari, H. (2025). Stability‐Indicating RP‐HPLC Method Development and Validation for Quantification of Butylated Hydroxyanisole Content in Loperamide Oral Solid Dosage Form. Biomedical Chromatography. https://doi.org/10.1002/bmc.70103

Vancouver

Lankalapalli PK, Kasa S, Sambu P, Myneni RK, Kamireddy T, Chollety V, et al. Stability‐Indicating RP‐HPLC Method Development and Validation for Quantification of Butylated Hydroxyanisole Content in Loperamide Oral Solid Dosage Form. Biomedical Chromatography. 2025. doi:10.1002/bmc.70103

BibTeX
@article{Lankalapalli2025,
  author = {Lankalapalli, Prasanna Kumar and Kasa, Srinivasulu and Sambu, Pranitha and Myneni, Rama Krishna and Kamireddy, Teja and Chollety, Vijaykumar and Divadari, Hareesh},
  title = {Stability‐Indicating RP‐HPLC Method Development and Validation for Quantification of Butylated Hydroxyanisole Content in Loperamide Oral Solid Dosage Form},
  journal = {Biomedical Chromatography},
  year = {2025},
  doi = {10.1002/bmc.70103}
}
Kostenlos starten →